Snowball logo
logo
MCAP

MedCap AB (publ)

MCAP ST
SEK 546.00-SEK 1.00  (0.18%)
Estimate
P/E
33.9
EPS
16.09
Beta
0.491
Growth
Revenue, YoY
16.22%
Net income, YoY
28.92%
FCF, YoY
75.98%
Forecast
P/E (FWD)
22.6
EPS (FWD)
24.17
About the company
Ticker
MCAP
ISIN
SE0009160872
Country
Sweden
Sector (GICS)
Healthcare
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orthotics. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 million ($2.75 million) and SEK150 million ($16.51 million) with enterprise value SEK50 million ($5.90 million) and SEK250 million ($23.06 million) and sales value between "5 million ($5.43 million) and "25 million ($27.18 million) and EBITDA between SEK1 million ($0.11 million) and SEK50 million ($5.50 million). The firm seeks to takes both minority and majority stakes. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.

Frequently asked questions

What sector does MedCap AB (publ) (MCAP) operate in?

MedCap AB (publ) belongs to the Healthcare sector and operates in the Medical Devices industry.

What is MedCap AB (publ) (MCAP) current stock price?

As of the latest data, MedCap AB (publ) stock price is SEK 546.00, with a previous close of SEK 547.00. MedCap AB (publ) lost -SEK 1.00 in the last trading session, representing a -0.18% loss.

What is MedCap AB (publ) (MCAP) current market capitalization?

MedCap AB (publ) market cap is approximately 8.18 billion.

What is MedCap AB (publ) (MCAP) Earnings Per Share (EPS)?

The trailing EPS is SEK 16.09, and the forward EPS is SEK 24.17.

What is MedCap AB (publ) (MCAP) Price-to-Earnings (P/E) ratio?

MedCap AB (publ) current P/E ratio is 33.93, with a forward P/E of 22.59.

What is MedCap AB (publ) (MCAP) EBITDA?

MedCap AB (publ) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 148.80 million.

Does MedCap AB (publ) (MCAP) pay dividends?

No. MedCap AB (publ) does not pay a dividend.

How did MedCap AB (publ) (MCAP) perform in its most recent earnings report?

In the last report (June 30, 2026), MedCap AB (publ) posted an EPS surprise of 15% and a revenue surprise of 5.63%.

When is MedCap AB (publ) (MCAP) next earnings report?

MedCap AB (publ) is expected to release its next earnings report on September 30, 2026.

What is MedCap AB (publ) (MCAP) beta (volatility) score?

MedCap AB (publ) has a beta of 0.491, indicating lower volatility than the overall market.